Bayer to Increase Packaging Production Capacity in China
Bayer HealthCare will invest around EUR 100 million ($138 million) to increase the production capacity of its plant in Beijing, China, in preparation for further demand of its products in the country. A respective agreement was signed March 28, 2014 in Germany on the occasion of the visit of the President of the People’s Republic of China, Xi Jinping, by the CEO of Bayer AG, Dr Marijn Dekkers. The planned capacity expansion is designed to ensure a reliable supply of products to meet the domestic demand for Bayer HealthCare's products, including the company's cardiovascular and anti-diabetes products. The expansion will include logistics areas for fully automated material handling, analytical laboratories, and high-speed packaging lines.
“The expansion of our Beijing site demonstrates our continuous strong commitment to the People’s Republic of China,” said Dr Olivier Brandicourt, CEO of Bayer HealthCare, in a press statement. “This investment will make Beijing the largest pharmaceuticals packaging site in Bayer HealthCare´s global production network.”
For the Bayer Group, Greater China is the largest single market in Asia, accounting for sales of around EUR 3.7 billion ($5.1 billion) in 2013. Currently more than 13,000 people work for the Bayer Group in China, which is also among the major focuses of the company’s global investment.
Source: Bayer HealthCare
